Company Overview
| Stock Name | 永勝醫療控股有限公司 |
|---|---|
| Stock Code | 01612 |
| Company Full Name | 永勝醫療控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要以ＯＥＭ（原廠設備制造）模式生產醫療器械，亦以「英仕醫療」品牌從事研發、生產及銷售各種醫療器械。 |
| Listing Date | 2016-07-13 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港九龍紅磡德豐街22號海濱廣場2座16樓1604-07A室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.vincentmedical.com |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 38,280,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 0.94 |
|---|---|
| First Day Open | HK$ 0.99 |
| First Day Change | -6.00% |
| First Day Volume | 31090000.0 |
| First Day Turnover | 29420600.0 |
Use of Proceeds
| Use of Proceeds | 1、約50.0%或47.9百萬港元用于2016年至2018年擴充及升級生產設施； 2、約27.0%或25.8百萬港元用于2016年至2018年開發在研及計劃中產品； 3、約18.0%或17.2百萬港元，用于2016年至2018年銷售及營銷； 4、約5.0%或4.8百萬港元，用于一般公司用途及營運資金。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
BOSC International Company Limited CE BDP643
Overall Coordinators (1)
BOSC International Company Limited CE BDP643
Joint Bookrunners (3)
BOSC International Company Limited CE BDP643
Crosby Securities Limited CE BAP681
申万宏源融资（香港）有限公司 CE ABC209
Joint Lead Managers (5)
BOSC International Company Limited CE BDP643
CGS-CIMB Securities (Hong Kong) Limited CE AAW351
Crosby Securities Limited CE BAP681
铠盛证券有限公司
申万宏源融资（香港）有限公司 CE ABC209
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 蔡文成 |
|---|---|
| Company Secretary | 徐麗琪 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 蔡文成(59.88%) |
|---|
